Usage of Glucagon-Like Peptide-1 for Obesity in Children; Updated Review of Clinicaltrials.gov
Nasser M Alorfi, Fahad S Alshehri Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi ArabiaCorrespondence: Nasser M Alorfi, Pharmacology and Toxicology Department, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia, Tel +966 500644261, E...
Main Authors: | Alorfi NM, Alshehri FS |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-07-01
|
Series: | Journal of Multidisciplinary Healthcare |
Subjects: | |
Online Access: | https://www.dovepress.com/usage-of-glucagon-like-peptide-1-for-obesity-in-children-updated-revie-peer-reviewed-fulltext-article-JMDH |
Similar Items
-
Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
by: Alessandro Mantovani, et al.
Published: (2021-01-01) -
The Impact of Glucagon-like Peptide 1 Receptor Agonists on Obstructive Sleep Apnoea: A Scoping Review
by: Khang Duy Ricky Le, et al.
Published: (2024-01-01) -
Emerging role of GLP-1 receptor agonists in the treatment of obesity
by: Neff LM
Published: (2010-07-01) -
Glucagon-like peptide-1 analogues: An overview
by: Vishal Gupta
Published: (2013-01-01) -
The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
by: Juan Pang, et al.
Published: (2022-11-01)